Sillajen said Thursday that it has presented partial sections of its phase 1 clinical trial for Pexa-Vec, a solid cancer treatment, at the American Society of Clinical Oncology in Chicago. According to Sillajen, the trial proved the safety and efficacy of Pexa-Vec on three patients with metastatic m...

SAN FRANCISCO and LONDON, May 14, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion diagnostics, today said investigators dosed the first patient in its Phase 1 trial of PolyPEPI™ 1018, th...

http://www.prweb.com/releases/2018/05/prweb15454899.htm PHILADELPHIA (PRWEB) MAY 01, 2018 Immunotherapy has given patients and oncologists new options, which for some patients, has meant cures for diseases that had been untreatable. Colorectal cancer has a high mortality rate in advanced stages of t...

Abstract More than half of human colorectal cancers (CRCs) carry either KRAS or BRAF mutations and are often refractory to approved targeted therapies. We found that cultured human CRC cells harboring KRAS or BRAF mutations are selectively killed when exposed to high levels of vitamin C. This effect...

Scientists have successfully turned off the excruciating pain that often accompanies a colorectal cancer drug in an animal model. Chemotherapy induced neuropathic pain (CINP) is a debilitating side effect that can appear as tingling or numbness in the hands and feet, shooting or burning pain in the ...

TASIN Selectively Targets Colon Cancer Cells Expressing Truncated APC A study conducted at the Departments of Biochemistry (Jef De Brabander) and Cell Biology (Jerry Shay), University of Texas Southwestern Medical Center, Dallas, TX has demonstrated that TASIN (Truncated APC Selective INhibitor), a...

Novel three-step pretargeted radioimmunotherapy offers safe, effective treatment Date: November 2, 2017 Source: Society of Nuclear Medicine and Molecular Imaging Summary: Researchers have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. In this...